Oxytocin: A therapeutic target for mental disorders

Mitsuhiro Matsuzaki, Hiroaki Matsushita, Kazuhito Tomizawa, Hideki Matsui

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood- brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.

Original languageEnglish
Pages (from-to)441-444
Number of pages4
JournalJournal of Physiological Sciences
Volume62
Issue number6
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Oxytocin
Mental Disorders
Antidepressive Agents
Therapeutics
Major Depressive Disorder
Autistic Disorder
Anxiety Disorders
Blood-Brain Barrier
Sexual Behavior
Pharmaceutical Preparations
Psychiatry
Schizophrenia
Central Nervous System
Depression
Brain

Keywords

  • CREB
  • Depression
  • MAP kinase
  • Oxytocin
  • Sildenafil

ASJC Scopus subject areas

  • Physiology

Cite this

Matsuzaki, M., Matsushita, H., Tomizawa, K., & Matsui, H. (2012). Oxytocin: A therapeutic target for mental disorders. Journal of Physiological Sciences, 62(6), 441-444. https://doi.org/10.1007/s12576-012-0232-9

Oxytocin : A therapeutic target for mental disorders. / Matsuzaki, Mitsuhiro; Matsushita, Hiroaki; Tomizawa, Kazuhito; Matsui, Hideki.

In: Journal of Physiological Sciences, Vol. 62, No. 6, 11.2012, p. 441-444.

Research output: Contribution to journalArticle

Matsuzaki, M, Matsushita, H, Tomizawa, K & Matsui, H 2012, 'Oxytocin: A therapeutic target for mental disorders', Journal of Physiological Sciences, vol. 62, no. 6, pp. 441-444. https://doi.org/10.1007/s12576-012-0232-9
Matsuzaki, Mitsuhiro ; Matsushita, Hiroaki ; Tomizawa, Kazuhito ; Matsui, Hideki. / Oxytocin : A therapeutic target for mental disorders. In: Journal of Physiological Sciences. 2012 ; Vol. 62, No. 6. pp. 441-444.
@article{6a69eacc42424735ad22c7b5a2afabb8,
title = "Oxytocin: A therapeutic target for mental disorders",
abstract = "We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood- brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.",
keywords = "CREB, Depression, MAP kinase, Oxytocin, Sildenafil",
author = "Mitsuhiro Matsuzaki and Hiroaki Matsushita and Kazuhito Tomizawa and Hideki Matsui",
year = "2012",
month = "11",
doi = "10.1007/s12576-012-0232-9",
language = "English",
volume = "62",
pages = "441--444",
journal = "Journal of Physiological Sciences",
issn = "1880-6546",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Oxytocin

T2 - A therapeutic target for mental disorders

AU - Matsuzaki, Mitsuhiro

AU - Matsushita, Hiroaki

AU - Tomizawa, Kazuhito

AU - Matsui, Hideki

PY - 2012/11

Y1 - 2012/11

N2 - We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood- brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.

AB - We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood- brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.

KW - CREB

KW - Depression

KW - MAP kinase

KW - Oxytocin

KW - Sildenafil

UR - http://www.scopus.com/inward/record.url?scp=84868543521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868543521&partnerID=8YFLogxK

U2 - 10.1007/s12576-012-0232-9

DO - 10.1007/s12576-012-0232-9

M3 - Article

C2 - 23007624

AN - SCOPUS:84868543521

VL - 62

SP - 441

EP - 444

JO - Journal of Physiological Sciences

JF - Journal of Physiological Sciences

SN - 1880-6546

IS - 6

ER -